Loading…

Zimmer Biomet has reached a definitive agreement to acquire Embody, a medical device company focused on soft tissue healing, for $155 million at closing plus up to $120 million in milestone payments. The acquisition strengthens Zimmer Biomet's sports medicine portfolio.
“The planned acquisition of Embody is an important step in the ongoing transformation of ZB and the execution of our strategic priority to increase long-term growth and drive value creation.”investor.zimmerbiomet.com
Summarized from public sources; check the original articles before acting on it.